Navigation Links
European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
Date:10/18/2007

r the treatment of HIV-1 infection in adults in the United States for use either as stand-alone therapy or in combination with other antiretroviral agents. ATRIPLA was approved by the U.S. Food and Drug Administration (FDA) in July 2006 and has since become the most-prescribed treatment regimen for patients starting HIV therapy in the United States.

The FDA also granted approval of an alternate tradedress of ATRIPLA for developing countries, where ATRIPLA is being made available as a white-colored tablet to distinguish it from the salmon-colored version currently available in the United States. In August 2006, Gilead and Merck established an agreement for distribution of the product in developing countries, and in March 2007, the World Health Organization added ATRIPLA to its Model List of Essential Medicines.

Important Product Safety Information About ATRIPLA (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), Emtriva (emtricitabine), Viread (tenofovir disoproxil fumarate [DF]) and Truvada (emtricitabine/tenofovir DF) in the United States

Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogues alone or in combination with other antiretrovirals.

Emtriva, Viread, Truvada and ATRIPLA are not approved for the treatment of chronic hepatitis B virus (HBV) infection and their safety and efficacy have not been established in patients co-infected with HBV and HIV. Severe acute exacerbations of hepatitis B have been reported in patients who have discontinued Viread or Emtriva, which are components of Truvada and ATRIPLA. In some of these patients treated with Emtriva, the exacerbations of hepatitis B were associated with liver decompensation and liver failure. Hepatic function should be monitored closely with both clinical and laboratory follow-up for at least several months in patients who are co-infected with HIV and HBV and discontinue Truvada o
'/>"/>

SOURCE Bristol-Myers Squibb
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. Malvern initiates European user group meetings for chemical imaging
7. PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
8. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
9. Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
10. Inspire Announces Presentations at Two European Scientific Conferences
11. Sunesis Pharmaceuticals Reports Positive Data From Studies of Two Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 28, 2015  Zipnosis, the first virtual care solution to ... launch their own branded virtual care service line, announced an ... CareNow is currently in use. ... As health ... recognize the value of providing their own branded online care ...
(Date:7/28/2015)... DUBLIN , July 21, 2015 ... the addition of the "Pharmaceutical Industry in ... Multinational and Chinese Biopharma Companies, Industry Trends, Environment, ... report to their offering. This ... in China but also ...
(Date:7/28/2015)... July 28, 2015  Alere Inc. (NYSE: ALR ... that it will release its financial results for the ... host a conference call beginning at 8:30 a.m. ET ... and provide business updates. The conference ... section of Alere,s website, or accessed directly through the ...
Breaking Medicine Technology:Zipnosis Announces Group Health to use Virtual Care Service Line 2Zipnosis Announces Group Health to use Virtual Care Service Line 3Pharmaceutical Industry in China to 2020: Market to Increase Dramatically to $200 Billion 2Alere to Report Second Quarter 2015 Financial Results on August 4, 2015 2
... (LSE: SHP, NASDAQ: SHPGY ), the global ... agreement with the Center for Drug Evaluation and Research ... to conduct additional clinical trials to confirm the clinical ... 1996 under Subpart H (an accelerated approval process) for ...
...   Remedi SeniorCare , one of the nation,s ... executive Corey Gauff as its new senior vice ... In his new position, Gauff will be responsible ... driving growth via Remedi,s innovative offerings, including the ...
Cached Medicine Technology:ProAmatine® (midodrine HCl) Update: Path Forward Agreed 2ProAmatine® (midodrine HCl) Update: Path Forward Agreed 3ProAmatine® (midodrine HCl) Update: Path Forward Agreed 4Remedi SeniorCare® Appoints Corey Gauff SVP of Sales and Account Management 2
(Date:7/28/2015)... ... July 28, 2015 , ... World Patent Marketing, a vertically ... that cleans pools efficiently - minus the backbreaking work. , "The Swimming Pool ... Director of World Patent Marketing. "It is a sleeping giant that has woken ...
(Date:7/28/2015)... ... 2015 , ... The Triumph Modular, Redefining Modular™ site offers ... library, floor plans, educational blog and wide use of imagery. The Design Build ... valuable links to useful reports by industry experts. Comments are welcomed and encouraged. ...
(Date:7/28/2015)... ... ... Mindful Her, a unique women’s wellness and lifestyle event designed to inspire ... to the next level, announced today an influential line-up of inspiring speakers, including Mallika ... Girls, an Orange County based non-profit that works locally and globally to help girls ...
(Date:7/28/2015)... ... July 28, 2015 , ... World Patent Marketing, ... new household invention that makes shelling eggs an exact science. , “The global ... Cooper, CEO and Creative Director of World Patent Marketing. “With a growth rate ...
(Date:7/28/2015)... FL (PRWEB) , ... July 28, 2015 , ... ... and The Miriam Hospital examines outcomes for inmates who continued methadone maintenance treatment ... latter group was more likely to relapse to opiate use (1) and more ...
Breaking Medicine News(10 mins):Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 2Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 3Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 4Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 5Health News:Triumph Modular Launches Refreshed Modular Building Industry Website 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 4Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 5Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4
... technology in India is very similar to the technology in ... States turning// towards India for filling up nursing vacancies. With ... imparted, nurses from India are realizing their dream of seeking ... infact recruited eight nurses from India who will be joining ...
... fresh bid to end the anti-reservation medicos strike in India, ... demand for an experts committee on quota in central educational ... decided to intensify the agitation by calling a bandh in ... hectic negotiations, the medicos held talks with Federal Minister Oscar ...
... for conducting global clinical trials due to availability of ... professionals and sophisticated technological infrastructure. // ,The ... Rs 3.1 billion in 2005 and is expected to ... the US and European nations are outsourcing clinical trials ...
... the US have created an artificial penis that has ... one day help treat men with severe erectile dysfunction.// ... colleagues at the Wake Forest Institute for Regenerative Medicine ... of tissue engineering, reported the online edition of New ...
... the Pakistani city of Faisalabad have been affected by contaminated ... number of victims of water-borne diseases, which broke out as ... Abad, seems to further increase as more people are being ... in the affected area is also underway. , ,'we ...
... seems not to have affected the resolve of the students ... a worse turn when two frustrated students tried to self ... Orissa. , ,Rishi Ranjan, 23, whom the police described ... Lila ground where medicos, who had gathered in strength, staged ...
Cached Medicine News:Health News:Two Students Try To Self-Immolate As Anti-Quota Stir Continues 2Health News:Two Students Try To Self-Immolate As Anti-Quota Stir Continues 3
Karlin Crank Frame Spinal Retractor Set is designed for posterior lumbar and thoracic spine surgery. Arm design allows the blades be pre-positioned in the wound prior to attachment....
The Boss Image-Trac system provides superior exposure for all surgical procedures from T1 to S1....
The Unitrac Retraction System is a pneumatic device that provides absolute rigid retraction and stable positioning to the operating room, freeing the surgical assistant to carry out higher priority t...
... Graft represents an rhBMP-2 (recombinant human bone ... bovine-derived absorbable collagen sponge (ACS) carrier. The ... is indicated for spinal fusion procedures in ... (DDD) at one level from L4-S1, who ...
Medicine Products: